Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-110142
Filing Date
2025-11-13
Accepted
2025-11-13 17:26:50
Documents
85
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0264964-10q_onconetix.htm   iXBRL 10-Q 1643039
2 CERTIFICATION ea026496401ex31_onconetix.htm EX-31 12408
3 CERTIFICATION ea026496401ex32_onconetix.htm EX-32 4813
  Complete submission text file 0001213900-25-110142.txt   9252618

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE onco-20250930.xsd EX-101.SCH 91616
5 XBRL CALCULATION FILE onco-20250930_cal.xml EX-101.CAL 59944
6 XBRL DEFINITION FILE onco-20250930_def.xml EX-101.DEF 448368
7 XBRL LABEL FILE onco-20250930_lab.xml EX-101.LAB 784062
8 XBRL PRESENTATION FILE onco-20250930_pre.xml EX-101.PRE 462567
87 EXTRACTED XBRL INSTANCE DOCUMENT ea0264964-10q_onconetix_htm.xml XML 1197772
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41294 | Film No.: 251479902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)